Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CUE BIOPHARMA INC | 0 | 52,928 | +52,928 | $0 | $1.67M | 7.99% | +$1.67M |
| Praxis Precision Medicines, Inc.(PRAX) | 4,450 | 4,450 | 0 | $1.43M | $1.49M | 7.13% | +$56.1K |
| MoonLake Immunotherapeutics(MLTX) | 67,500 | 67,500 | 0 | $1.26M | $1.31M | 6.29% | +$56.0K |
| FENNEC PHARMACEUTICALS INC | 112,434 | 112,434 | 0 | $691.5K | $1.21M | 5.78% | +$517.2K |
| Royalty Pharma plc(RPRX) | 21,400 | 21,400 | 0 | $1.03M | $1.20M | 5.74% | +$173.3K |
| COMPASS Pathways plc(CMPS) | 80,000 | 80,000 | 0 | $442.4K | $1.13M | 5.41% | +$689.6K |
| MILESTONE PHARMACEUTICALS IN | 820,000 | 820,000 | 0 | $975.8K | $1.10M | 5.26% | +$123.0K |
| BENITEC BIOPHARMA INC | 62,000 | 62,000 | 0 | $660.3K | $829.6K | 3.97% | +$169.3K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 36,000 | 36,000 | 0 | $841.0K | $787.0K | 3.76% | -$54.0K |
| Biohaven Ltd.(BHVN) | 51,700 | 51,700 | 0 | $437.4K | $769.3K | 3.68% | +$331.9K |
| GERON CORP | 578,000 | 578,000 | 0 | $861.2K | $739.8K | 3.54% | -$121.4K |
| uniQure N.V.(QURE) | 14,700 | 14,700 | 0 | $240.3K | $677.1K | 3.24% | +$436.7K |
| ARDELYX INC | 128,650 | 128,650 | 0 | $770.6K | $656.1K | 3.14% | -$114.5K |
| Lantheus Holdings, Inc.(LNTH) | 5,500 | 5,500 | 0 | $417.2K | $610.2K | 2.92% | +$193.0K |
| Disc Medicine, Inc.(IRON) | 8,100 | 8,100 | 0 | $517.9K | $592.4K | 2.83% | +$74.5K |
| Sarepta Therapeutics, Inc.(SRPT) | 28,500 | 28,500 | 0 | $620.2K | $512.1K | 2.45% | -$108.0K |
| HUMACYTE INC | 650,000 | 650,000 | 0 | $394.4K | $507.3K | 2.43% | +$112.9K |
| Kura Oncology, Inc.(KURA) | 46,000 | 46,000 | 0 | $374.0K | $504.6K | 2.41% | +$130.6K |
| Viatris Inc.(VTRS) | 27,700 | 27,700 | 0 | $374.2K | $439.9K | 2.10% | +$65.6K |
| Dyne Therapeutics, Inc.(DYN) | 18,000 | 18,000 | 0 | $326.3K | $399.8K | 1.91% | +$73.4K |
| BridgeBio Pharma, Inc.(BBIO) | 5,000 | 5,000 | 0 | $371.3K | $372.4K | 1.78% | +$1.1K |
| Edgewise Therapeutics, Inc.(EWTX) | 9,100 | 9,100 | 0 | $286.6K | $369.7K | 1.77% | +$83.1K |
| Pacira BioSciences, Inc.(PCRX) | 13,500 | 13,500 | 0 | $305.1K | $342.5K | 1.64% | +$37.4K |
| REGENXBIO INC | 26,600 | 26,600 | 0 | $222.9K | $318.7K | 1.52% | +$95.8K |
| ROCKET PHARMACEUTICALS INC | 86,000 | 86,000 | 0 | $307.9K | $294.1K | 1.41% | -$13.8K |
| Janux Therapeutics, Inc.(JANX) | 19,000 | 19,000 | 0 | $264.1K | $291.8K | 1.40% | +$27.7K |
| Mineralys Therapeutics, Inc.(MLYS) | 10,500 | 10,500 | 0 | $284.4K | $283.3K | 1.36% | -$1.2K |
| GH Research PLC(GHRS) | 10,200 | 10,200 | 0 | $143.4K | $274.2K | 1.31% | +$130.8K |
| SERES THERAPEUTICS INC | 31,570 | 31,570 | 0 | $280.0K | $249.1K | 1.19% | -$30.9K |
| Azenta, Inc.(AZTA) | 9,700 | 9,700 | 0 | $205.0K | $247.5K | 1.18% | +$42.6K |
| JASPER THERAPEUTICS INC | 465,000 | 465,000 | 0 | $407.4K | $195.8K | 0.94% | -$211.7K |
| Innoviva, Inc.(INVA) | 8,200 | 8,200 | 0 | $191.1K | $186.2K | 0.89% | -$4.8K |
| INNATE PHARMA S A | 81,151 | 81,151 | 0 | $103.9K | $149.3K | 0.71% | +$45.4K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 5,250 | 5,250 | 0 | $123.7K | $137.7K | 0.66% | +$14.0K |
| SPRUCE BIOSCIENCES INC | 1,000 | 1,000 | 0 | $65.3K | $54.0K | 0.26% | -$11.3K |
| CUE BIOPHARMA INC | 2,202,854 | 0 | -2,202,854 | $506.4K | $0 | — | -$506.4K |